易瑞生物控股股东及其一致行动人拟减持不超3%股份

Core Viewpoint - The major shareholders of EasyBio plan to reduce their holdings in the company through centralized bidding or block trading from November 3, 2025, to February 2, 2026, due to personal funding needs [1][2]. Shareholder Reduction Details - EasyBio's controlling shareholder, EasyBio (Hainan) Venture Capital Co., Ltd., holds 132,369,971 shares, accounting for 32.68% of the total share capital, and plans to reduce holdings by up to 11,521,758 shares (2.84% of total share capital) - EasyDari holds 19,008,003 shares (4.69%) and plans to reduce by up to 288,500 shares (0.07%) - EasyKairi holds 22,577,203 shares (5.57%) and plans to reduce by up to 341,800 shares (0.08%) - The total planned reduction does not exceed 3% of the company's total share capital [2]. Shareholder Commitment Compliance - EasyBio's shareholders have adhered to their commitments regarding share lock-up and reduction intentions as stated in the IPO prospectus and listing announcement documents - As of the announcement date, there have been no violations of these commitments by the three shareholders [3]. Impact of Reduction - The reduction plan carries uncertainties regarding timing, quantity, and price - The company asserts that this reduction is a normal behavior of shareholders and will not significantly impact the governance structure, equity structure, or future operations of the company, nor will it lead to a change in control - The shareholders will comply with relevant laws and regulations during the reduction period and fulfill disclosure obligations in a timely manner [4].